Check if trademark MIRAPEX ER is available

USPTO Filing History

Key events recorded for this trademark application

2008-11-04 — Application filed
2008-11-07 — Application filed
2008-12-30 — Assigned to examiner
2009-01-09 — Final disposition recorded
2009-01-12 — Final disposition recorded
2009-02-17 — Paper received
2009-02-18 — Approved for pub - principal register
2009-02-18 — Amendment from applicant entered
2009-02-18 — Assigned to lie
2009-02-18 — Correspondence received in law office
2009-02-19 — Law office publication review completed
2009-03-04 — Notice of publication
2009-03-24 — Published for opposition
2009-04-23 — Extension of time to oppose received
2009-06-01 — Paper received
2009-08-07 — Extension of time to oppose process - terminated
2009-08-12 — Assigned to petition staff
2009-08-13 — Post publication amendment - entered
2009-09-22 — Noa mailed - sou required from applicant
2010-03-22 — Use amendment filed
2010-03-22 — Paper received
2010-04-20 — Case assigned to intent to use paralegal
2010-04-20 — Statement of use processing complete
2010-05-17 — Final disposition recorded
2010-05-18 — Final disposition recorded
2010-07-14 — Paper received
2010-07-16 — Allowed principal register - sou accepted
2010-07-16 — Amendment from applicant entered
2010-07-16 — Correspondence received in law office
2010-07-19 — Law office registration review completed
2010-07-20 — Notice of acceptance of statement of use mailed
2010-08-24 — Registered-principal register
2017-04-07 — Cancelled sec. 8 (6-yr)
2017-04-07 — Final status recorded

Owner Information

Boehringer Ingelheim Pharma GmbH & Co. KG
Ingelheim am Rhein DE

Correspondent

MARTIN J. BERAN OSTROLENK, FABER, GERB & SOFFEN, LLP
1180 AVENUE OF THE AMERICAS FL 7
NEW YORK, NY 10036-8443
UNITED STATES

Filing Details

Filing Date:
2008-11-04

Status Date:
2017-04-07

Category:
Pharmaceuticals

Filing Year:
2008